Ascendis Pharma A/S
ASND
Clasificación en acciones
#1497
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing... Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding its innovative portfolio, Ascendis is also developing a TransCon toll-like receptor (TLR) 7/8 agonist for intratumoral administration, alongside TransCon IL-2 ß/g, designed for systemic delivery. Founded in 2006, this enterprise maintains its corporate headquarters in Hellerup, Denmark.
Precio por acción
$234.15
Capitalización bursátil
$14.61B
Cambio (1 día)
1.82%
Cambio (1 año)
14.10%
País
DK
Comercio Ascendis Pharma A/S (ASND)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Ascendis Pharma A/S (ASND)
La acción Ascendis Pharma A/S (símbolo: ASND) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Oct 20, 2026.
Una acción ASND comprada antes de Oct 20, 2026 equivaldría hoy a 0 acciones ASND.
El desdoblamiento más reciente ocurrió el Oct 20, 2026.
Una acción ASND comprada antes de Oct 20, 2026 equivaldría hoy a 0 acciones ASND.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
